Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 16 Oct 20 424B4 Prospectus supplement with pricing info
- 16 Oct 20 EFFECT Notice of effectiveness
- 6 Oct 20 FWP Free writing prospectus
-
6 Oct 20 S-1/A IPO registration (amended)
- 3 Sep 20 S-1/A IPO registration (amended)
- 24 Aug 20 FWP Free writing prospectus
- 24 Aug 20 S-1/A IPO registration (amended)
- 5 Aug 20 FWP Free writing prospectus
- 5 Aug 20 S-1/A IPO registration (amended)
- 21 Jul 20 FWP Free writing prospectus
- 13 Jul 20 S-1/A IPO registration (amended)
- 26 Jun 20 S-1/A IPO registration (amended)
- 11 May 20 S-1 IPO registration
KRBP similar filings
Filing view
External links
QuickLinks -- Click here to rapidly navigate through this document
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the use in this Registration Statement No. 333-238153 on Form S-1 of our report dated April 6, 2020, (June 25, 2020 as to the effects of the reverse stock split described in Notes 2 and 12) relating to the financial statements of Kiromic BioPharma, Inc. We also consent to the reference to us under the heading "Experts" in such Registration Statement.
/s/ Deloitte & Touche LLP
Houston, Texas
October 6, 2020